Fiche centre
UCSF
San Francisco — United States
Essais liés7clinical trials
VilleSan Franciscolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT04675398
Essais cliniques associés
7| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Pelacarsen (TQJ230) | Accident vasculaire cérébral | Phase 3 | NCT07517263 | An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) | ACTIVE_NOT_RECRUITING |
| Summit RC+S | Parkinson | Non applicable | NCT04675398 | Adaptive Deep Brain Stimulation to Improve Motor and Gait Functions in Parkinson's Disease | ACTIVE_NOT_RECRUITING |
| rapcabtagene autoleucel | Lupus | Phase 2 | NCT06581198 | A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) | ACTIVE_NOT_RECRUITING |
| TRI-611 | Cancer | Phase 1/2 | NCT07491497 | A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC | RECRUITING |
| IL1 Inhibition in FOP | Myopathies | À vérifier | NCT06724562 | IL1 Inhibition in FOP | RECRUITING |
| Interferon beta-1a | SEP | Phase 3 | NCT01892722 | Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis | ACTIVE_NOT_RECRUITING |
| Ofatunumab | SEP | Phase 4 | NCT06444113 | KATHAROS — Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis | ACTIVE_NOT_RECRUITING |